Margarita Merkulova – Program Manager in Analytics, Umicore • Prof. Dr. ir. Mark Huijben – Full Professor, University of Twente • Xuehang Wang – A ...

The company is expected to generate over $300 million in free cash flow by 2025, reducing net leverage from 2x to 1x, and potentially re-rating the stock to $70/share. Collegium Pharmaceutical ...

Morgan Stanley analyst Sean Laaman assumed coverage of Jazz Pharmaceuticals (JAZZ) with an Overweight rating and a price target of $183, up from $175. The firm model higher oxybate revenue than ...

The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. These financial ...

The agency noted that an investigation conducted by the British Broadcasting Corporation “exposed how packets of these drugs, branded with the Aveo Pharmaceuticals logo, have been found on the ...

Madrigal Pharmaceuticals (MDGL) reported Q4 results and provided a 2-year update from the open-label metabolic dysfunction-associated steatohepatitis compensated F4 arm of the Phase 3 MAESTRO ...

SAN RAFAEL, Calif., Feb. 24, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has appointed Timothy P. Walbert, former chairman, president and ...

NORTHFIELD, Minn., Feb. 13, 2025 /PRNewswire/ -- Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx ® (firocoxib), a non ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch ...